FDA approves new AI software for brain bleed diagnosis

Michael Walter | | Radiology Business | Artificial Intelligence

MaxQ AI’s Accipio Ix intracranial hemorrhage (ICH) detection software has gained FDA clearance, the company announced this week. The software helps providers assess non-contrast head CT examinations for signs of ICH, also known as brain bleed.

Gene Saragnese, chairman and CEO of MaxQ AI, said in a prepared statement that this software is the first of many that will make up the company’s Accipio ecosystem of products. It has already gained CE Mark approval.

The software was designed to use AI technology without storing the patient’s protected health information or altering the original CT images in any way. Patients showing signs of ICH are identified and prioritized.

“The potential impact is massive—only one patient diverted from acute stroke to wellness in the 13,000 U.S./E.U. hospitals represent $2 billion savings in a single year, and a lifetime of difference to the patient and their families,” Saragnese said in the same statement.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Navigating the radiology workforce shortage: 6 potential solutions
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care
RSNA 2024 Program Chair Kate Hanneman highlights key trends in radiology
Do large language models help or hinder workflows related to radiology reports?
Hospital creates 'virtual reality technologist' role to support patients during interventional procedures

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.